Exchange Traded Concepts’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.47M Sell
144,265
-1,660
-1% -$69.6K 0.04% 381
2026
Q1
$4.7M Buy
145,925
+34,981
+32% +$1.29M 0.03% 415
2025
Q4
$4.67M Sell
110,944
-21,490
-16% -$866K 0.04% 423
2025
Q3
$4.55M Buy
132,434
+17,393
+15% +$499K 0.04% 417
2025
Q2
$3.11M Buy
115,041
+23,047
+25% +$668K 0.04% 409
2025
Q1
$2.73M Buy
91,994
+22,565
+33% +$860K 0.05% 317
2024
Q4
$2.75M Sell
69,429
-21,414
-24% -$811K 0.05% 305
2024
Q3
$3.09M Sell
90,843
-41,458
-31% -$1.17M 0.07% 232
2024
Q2
$2.87M Sell
132,301
-12,106
-8% -$255K 0.07% 226
2024
Q1
$3.2M Buy
144,407
+50,506
+54% +$1.23M 0.08% 219
2023
Q4
$2.58M Buy
93,901
+13,482
+17% +$325K 0.07% 221
2023
Q3
$1.8M Buy
80,419
+11,966
+17% +$308K 0.05% 259
2023
Q2
$1.74M Buy
68,453
+2,395
+4% +$58.1K 0.04% 289
2023
Q1
$1.47M Buy
66,058
+8,804
+15% +$213K 0.04% 256
2022
Q4
$1.36M Sell
57,254
-25,910
-31% -$602K 0.04% 252
2022
Q3
$1.38M Sell
83,164
-31,194
-27% -$702K 0.05% 201
2022
Q2
$2.28M Buy
114,358
+6,072
+6% +$123K 0.07% 152
2022
Q1
$2.98M Buy
108,286
+13,328
+14% +$381K 0.06% 177
2021
Q4
$3.91M Buy
94,958
+13,284
+16% +$587K 0.08% 155
2021
Q3
$3.79M Sell
81,674
-31,353
-28% -$1.37M 0.1% 137
2021
Q2
$4.52M Buy
113,027
+72,637
+180% +$3.11M 0.14% 104
2021
Q1
$2.17M Buy
40,390
+19,481
+93% +$1.12M 0.08% 194
2020
Q4
$1.02M Sell
20,909
-1,995
-9% -$92.4K 0.05% 222
2020
Q3
$744K Buy
22,904
+7,892
+53% +$251K 0.04% 202
2020
Q2
$389K Buy
15,012
+8,964
+148% +$223K 0.06% 247
2020
Q1
$147K Buy
6,048
+3,113
+106% +$78.4K 0.08% 223
2019
Q4
$82K Buy
+2,935
New +$76K 0.02% 226

Other funds holding VCYT

Exchange Traded Concepts's VCYT Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Veracyte (VCYT) stake by 1.1% in Q2 2026, selling an estimated $69.6K and leaving 144,265 shares worth $8.47M. The position accounts for 0.04% of the portfolio, ranked #381.

Exchange Traded Concepts first reported a position in VCYT in Q4 2019 and has held it in 27 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Exchange Traded Concepts held 144,265 shares of Veracyte worth $8.47M as of Q2 2026.
  • Exchange Traded Concepts sold 1,660 Veracyte shares in Q2 2026, an estimated $69.6K.
  • Veracyte made up 0.04% of Exchange Traded Concepts's portfolio in Q2 2026, its #381 holding.
  • Exchange Traded Concepts first reported a position in Veracyte in Q4 2019 and has held it in 27 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.